Your browser doesn't support javascript.
loading
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I.
Sebai, Molka; Tulasne, David; Caputo, Sandrine M; Verkarre, Virginie; Fernandes, Marie; Guérin, Célia; Reinhart, Fanny; Adams, Séverine; Maugard, Christine; Caron, Olivier; Guillaud-Bataille, Marine; Berthet, Pascaline; Bignon, Yves-Jean; Bressac-de Paillerets, Brigitte; Burnichon, Nelly; Chiesa, Jean; Giraud, Sophie; Lejeune, Sophie; Limacher, Jean-Marc; de Pauw, Antoine; Stoppa-Lyonnet, Dominique; Zattara-Cannoni, Hélène; Deveaux, Sophie; Lidereau, Rosette; Richard, Stéphane; Rouleau, Etienne.
Afiliação
  • Sebai M; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Tulasne D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
  • Caputo SM; Department of Genetics, Institut Curie, Paris, France.
  • Verkarre V; Paris Sciences Lettres Research, Paris University, Paris, France.
  • Fernandes M; Department of Pathology, Georges Pompidou European Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Guérin C; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Reinhart F; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
  • Adams S; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
  • Maugard C; Department of Pathology, Georges Pompidou European Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Caron O; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Guillaud-Bataille M; Department of Molecular Oncogenetics, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Berthet P; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Bignon YJ; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Bressac-de Paillerets B; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Burnichon N; Oncogenetics Department, Centre François Baclesse, Caen, France.
  • Chiesa J; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Giraud S; Oncogenetics Department, Centre Jean-Perrin, Clermont-Ferrand, France.
  • Lejeune S; Department of Medical Biology and Pathology, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France.
  • Limacher JM; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • de Pauw A; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Stoppa-Lyonnet D; Genetics Department, AP-HP, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France.
  • Zattara-Cannoni H; Department of Cytogenetics, Nimes University Hospital, Nîmes, France.
  • Deveaux S; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Lidereau R; Genetics Department, Hospices Civils de LYON (HCL), Lyon, France.
  • Richard S; French National Network for Rare Cancers in Adults PREDIR labelled by INCa, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Rouleau E; Department of Genetics, CHRU Lille, Lille, France.
Hum Mutat ; 43(3): 316-327, 2022 03.
Article em En | MEDLINE | ID: mdl-34882875
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Carcinoma de Células Renais / Proteínas Proto-Oncogênicas c-met / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Carcinoma de Células Renais / Proteínas Proto-Oncogênicas c-met / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article